Navigation Links
Stem Cell Agency Finally Reveals Institutions Involved in Conflict Problem
Date:12/12/2007

After Public Pressure, Five Research Institutions Are Identified During Grant Award Discussion

LOS ANGELES, Dec. 12 /PRNewswire-USNewswire/ -- The California stem cell agency's decision today to reveal the names of five research institutions whose applications for research grants were rejected because of possible conflict of interest violations was correct, the Foundation for Taxpayer and Consumer Rights (FTCR) said.

But the non-partisan, non-profit organization stressed that the names of the institutions should have been released as soon as the problem came to light.

"Holding back the details simply undermines the public's trust in the stem cell agency," said John M. Simpson, FTCR's Stem Cell Project Director. "I don't understand their propensity for secrecy. It serves neither the board nor the agency nor the public."

The institutions involved are UC San Francisco, UC San Diego, UCLA, University of Southern California and the Burnham Institute for Medical Research. Officials at the institutions who are also members of the stem cell board signed letters supporting applications for research grants.

The 29-member oversight committee met at UCLA today and awarded $54.4 million in grants for young faculty members beginning their research careers. After 10 applications were rejected because of the conflict problem, 48 applications were under consideration. The board approved 22 grants.

It is expected that another call for young faculty grants will be approved at the board's January meeting. The 10 rejected applicants, as well as others, could apply in that round. Before the applications were tossed out, the board expected to authorize $85 million in grants.

"The stem cell agency continues too frequently to operate as if it were a private club or foundation, not the $6 billion state agency it in fact is," said Simpson. "This unwarranted veil of secrecy undermines public trust in the agency and ultimatel
'/>"/>

SOURCE Foundation for Taxpayer and Consumer Rights
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. ImmuneRegen Responds to Defense Threat Reduction Agency Request for Information
2. Pharmion and MethylGene Announce Orphan Drug Designation Granted by the European Medicines Agency (EMEA) for MGCD0103 for the Treatment of Hodgkins Lymphoma
3. International Atomic Energy Agency and National Foundation for Cancer Research Launch Major Initiative to Improve Cancer Prevention and Treatments in Developing Countries
4. Sequella Lead Drug Compound SQ109 Receives Orphan Drug Status From the US FDA and Orphan Medicinal Product Designation From the European Medicines Agency for the Treatment of Tuberculosis
5. New Survey Reveals Many Adults With High Cholesterol Fail to Take Necessary Steps to Improve Their Condition
6. New paper reveals nanoscale details of photolithography process
7. Ohio Academic Institutions Increase Research and Development Investments
8. California Stem Cell Board Member Violates Conflict Rules; Should Resign From Committee, Consumer Group Says
9. A Large-Scale Research Project by a Dutch Consortium Addressing a Global Problem
10. New Licence for Cubicin(R) (daptomycin), the First in a Novel Class of Antibiotic, is Announced Today for the Treatment of Serious Bloodstream and Heart Infections Caused by the Most Problematic UK Organisms, Including MRSA

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... REYKJAVIK, Iceland, November 24 /PRNewswire-Fi...today announced the approval of all of its,"first ...District of Delaware,(the "Bankruptcy Court"). deC...f under Chapter 11 of the United States Bankruptcy...ders issued by the Bankruptcy Court allow the comp...
(Date:11/24/2009)...GHAI, Nov. 24 /PRNewswire-Asia/ -- Shanghai Biolax...nistration (SFDA) has approved the,investigational...roject,(Nodlin), an innovative insulin formulation...xy to initiate its first phase I clinical study. ,... high blood glucose and poor,metabolism. The compl...
(Date:11/24/2009)... efficacy endpoint has been met for patients with ..., , QUEBEC CITY, Nov. 24 /PRNewswire-FirstCal...EZ) (the "Company"), a global biopharmaceutical co...oday announced positive efficacy data from a Phase...gate, AEZS-108 (formerly AN-152), in patients with...
(Date:11/24/2009)..., Nov. 24, 2009 Arena Ph...oday that the company is scheduled to present at t...e on December 1, 2009 at 11:30 a.m. Eastern Time (...el in New York City. Jack Lief, Arena,s President ...de an overview of the company, including its clini...
Breaking Biology Technology:deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3Biolaxy Secures IND Approval for Oral Insulin 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 3
...enta,Incorporated (OTC Bulletin Board: GNTA) today... June 30, 2008. The Company recorded significant,m...lowing:, -- NDA amendment for Genasense(R) in CLL...asense in melanoma updated at EADO, -- Clinical h...axane,lifted by FDA, -- Pharmacokinetics of or...
...stretchable optoelectronics and biologically inspi...maging device, with a layout based on the human ey... Nature, researchers at the University of Illino...gh-performance, hemispherical "eye" camera using a...d electronics, configured in a stretchable, interc...
...r service revenue grows approximately 33% ... - Operating margin of 9.9% for the quarter,- Rec...atio of 1.56 for the ...Corporation (Nasdaq: PRXL ) today announced its f... Year ended June 30, 2008., For the three months ...
Other Biology Technology:Genta Incorporated Announces Second Quarter 2008 Financial Results and Corporate Highlights 2Genta Incorporated Announces Second Quarter 2008 Financial Results and Corporate Highlights 3Genta Incorporated Announces Second Quarter 2008 Financial Results and Corporate Highlights 4Genta Incorporated Announces Second Quarter 2008 Financial Results and Corporate Highlights 5Genta Incorporated Announces Second Quarter 2008 Financial Results and Corporate Highlights 6Genta Incorporated Announces Second Quarter 2008 Financial Results and Corporate Highlights 7Genta Incorporated Announces Second Quarter 2008 Financial Results and Corporate Highlights 8Genta Incorporated Announces Second Quarter 2008 Financial Results and Corporate Highlights 9Genta Incorporated Announces Second Quarter 2008 Financial Results and Corporate Highlights 10Stretchable silicon camera next step to artificial retina 2PAREXEL Reports Fourth Quarter and Fiscal Year 2008 Financial Results 2PAREXEL Reports Fourth Quarter and Fiscal Year 2008 Financial Results 3PAREXEL Reports Fourth Quarter and Fiscal Year 2008 Financial Results 4PAREXEL Reports Fourth Quarter and Fiscal Year 2008 Financial Results 5PAREXEL Reports Fourth Quarter and Fiscal Year 2008 Financial Results 6PAREXEL Reports Fourth Quarter and Fiscal Year 2008 Financial Results 7PAREXEL Reports Fourth Quarter and Fiscal Year 2008 Financial Results 8PAREXEL Reports Fourth Quarter and Fiscal Year 2008 Financial Results 9PAREXEL Reports Fourth Quarter and Fiscal Year 2008 Financial Results 10PAREXEL Reports Fourth Quarter and Fiscal Year 2008 Financial Results 11PAREXEL Reports Fourth Quarter and Fiscal Year 2008 Financial Results 12PAREXEL Reports Fourth Quarter and Fiscal Year 2008 Financial Results 13PAREXEL Reports Fourth Quarter and Fiscal Year 2008 Financial Results 14
(Date:11/25/2009)...ate University assistant professors recently recei...NSF) to continue research beneficial to understand...00. , Christopher Blackwood, assistant professor...rded grants to support two separate research proje...ter Decomposer Communities and Functions from the ...
(Date:11/24/2009)...have crystallised a protein that may help gut bact...in could be used by probiotic producers to identif... people. , "Probiotics need to interact with cell...if they attach to surfaces in the gut they are mor...r activity," says Dr Nathalie Juge from the Instit...
(Date:11/24/2009)...GE Antarctica has long held secrets of the earth,...ntly, there has been very little information on th... of ice for millions of years. Now, a team of rese...e been funded to the tune of $10 million dollars b...to the bottom of things literally. These scientis...
Breaking Biology News(10 mins):Kent State University professors focus research on the environment with grants totaling $890,000 2A sticky solution for identifying effective probiotics 2LSU gets to the bottom of things -- in Antarctica 2Food Addicts Convention Draws 800 Members from 31 States 5 Nations Around the World 58152 1Food Addicts Convention Draws 800 Members from 31 States 5 Nations Around the World 58152 2Food Addicts Convention Draws 800 Members from 31 States 5 Nations Around the World 58152 3InspireMD Announces the Enrollment of the 1st Patient in the MGuard 28TM 29 Israeli Registry InspireMD Will Also Sponsor a Satellite Program Breakfas 14237 1InspireMD Announces the Enrollment of the 1st Patient in the MGuard 28TM 29 Israeli Registry InspireMD Will Also Sponsor a Satellite Program Breakfas 14237 2InspireMD Announces the Enrollment of the 1st Patient in the MGuard 28TM 29 Israeli Registry InspireMD Will Also Sponsor a Satellite Program Breakfas 14237 3Max Neeman International to Open Phase I IIa Unit 14233 1Max Neeman International to Open Phase I IIa Unit 14233 2
...des an effective way to screen drugs against Hunti...ntine and riluzole ?are most effective at keeping ...er, UT Southwestern Medical Center researchers rep...y of Huntington,s disease models and some HD human...t," said Dr. Ilya Bezprozvanny, associate professo...
...ucted the DNA sequence of a 5-million-year-old ret...tious particles. The retrovirus--named Phoenix--i...ments, some of which may play a role in cancer. T...ious retrovirus from a mobile element in the human...d of retrovirus research. The findings are report...
...own that a three-dimensional ultrasound scanner th...ot. , The scanner could find application in variou...They said the scanner ultimately might enable surg...ty that could prove valuable in space stations or ...to our knowledge, that anyone has used the informa...
Other Biology News:Test reveals effectiveness of potential Huntington's disease drugs 2Scientists resuscitate a 5 million-year-old retrovirus 23-D ultrasound scanner could guide robotic surgeries 23-D ultrasound scanner could guide robotic surgeries 3
Donor feline Serum - 100mL from Biomeda Corporation
Monocyte Activation Kit from 3H Biomedical AB
Goat Anti-NPT1 (M-19) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Suction Cups and Assemblies from Parker Hannifin Corporation
Biology Products: